Kosuke Ohsawa

Dr. Kosuke Ohsawa

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2017 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
LLLuca Laraia
Luca Laraia
KOKosuke Ohsawa
Kosuke Ohsawa
GKGeorgios Konstantinidis
Georgios Konstantinidis
LRLucas Robke
Lucas Robke
YWYao‐Wen Wu
Yao‐Wen Wu
HWHerbert Waldmann
Herbert Waldmann

11 March 2013 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
KOKosuke Ohsawa
Kosuke Ohsawa
MYMasahito Yoshida
Masahito Yoshida
TDTakayuki Doi
Takayuki Doi

16 May 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
CMChitose Maruyama
Chitose Maruyama
YCYukiko Chinone
Yukiko Chinone
SSShusuke Sato
Shusuke Sato
FKFumitaka Kudo
Fumitaka Kudo
KOKosuke Ohsawa
Kosuke Ohsawa
YHYoshimitsu Hamano
Yoshimitsu Hamano
Many pharmacologically important peptides are bacterial or fungal in origin and contain nonproteinogenic amino acid (NPA) building blocks. Recently, it was reported that, in bacteria, a cyclopropane-containing NPA 1-aminocyclopropanecarboxylic acid (ACC) is produced from the L-methionine moiety of S-adenosyl-L-methionine (SAM) by non-canonical ACC-forming enzymes. On the other hand, it has been suggested that a monomethylated ACC analogue, 2-methyl-ACC (MeACC), is derived from L-valine. Therefore, we have investigated the MeACC biosynthesis by identifying a gene cluster containing bacterial MeACC synthase genes. In this gene cluster, we identified two genes, orf29 and orf30, which encode a cobalamin (B12)-dependent radical SAM methyltransferase and a bacterial ACC synthase, respectively, and were found to be involved in the MeACC biosynthesis. In vitro analysis using their recombinant enzymes (rOrf29 and rOrf30) further revealed that the ACC structure of MeACC was derived from the L-methionine moiety of SAM, rather than L-valine. In addition, rOrf29 was found to catalyze the C-methylation of the L-methionine moiety of SAM. The resulting methylated derivative of SAM was then converted into MeACC by rOrf30. Thus, we demonstrate that C-methylation of SAM occurs prior to cyclopropanation in the biosynthesis of a bacterial MeACC (norcoronamic acid).

9 May 2019 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
KOKosuke Ohsawa
Kosuke Ohsawa
MSMasato Sugai
Masato Sugai
LZLinnan Zhang
Linnan Zhang
YMYuichi Masuda
Yuichi Masuda
MYMasahito Yoshida
Masahito Yoshida
TDTakayuki Doi
Takayuki Doi

6 January 2014 in Chemical Science
Verified
Journal Article
Closed access
PDF file
TDTakayuki Doi
Takayuki Doi
MYMasahito Yoshida
Masahito Yoshida
KOKosuke Ohsawa
Kosuke Ohsawa
KSKazuo Shin-Ya
Kazuo Shin-Ya
MTMotoki Takagi
Motoki Takagi
TNTohru Natsume
Tohru Natsume
We have characterized the inhibition of the protein–protein interaction of the homodimer of proteasome assembling chaperone (PAC) 3 with thielocin B1, discovered from natural product sources. Molecular modeling using docking studies and molecular dynamics simulation suggested that thielocin B1 exhibits distinct binding positions on the interface of the homodimer and the complex can be stabilized by five interactive residues on PAC3. Thielocin B1 was synthesized for the first time and was utilized for nuclear magnetic resonance (NMR) titration of the PAC3 homodimer. The data revealed significant chemical shift perturbations observed in eight residues on PAC3. We also synthesized a spin-labeled derivative to observe paramagnetic relaxation enhancement (PRE) effects. As a result, distinct decrease of the intensities of the NH peaks was observed in sixteen residues of PAC3 in the presence of the spin-labeled derivative. Both the NMR experiments and further in silico docking studies have suggested that thielocin B1 approaches one face of the PAC3 homodimer, not the monomer, releasing the subunit of the interface of the PAC3 homodimer by a rare pre-dissociation-independent mechanism.

13 August 2018 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
NSNorihiko Sugisawa
Norihiko Sugisawa
SOShinobu Ohnuma
Shinobu Ohnuma
HUHirofumi Ueda
Hirofumi Ueda
MMMegumi Murakami
Megumi Murakami
KSKyoko Sugiyama
Kyoko Sugiyama
MUMichiaki Unno
Michiaki Unno